The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver.

The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver.

Genome-wide association studies have identified a number of signals for both Type 2 Diabetes and related quantitative traits. For the majority of loci, the transition from association signal to mutational mechanism has been difficult to establish. Glucokinase (GCK) regulates glucose storage and disp...

Podrobná bibliografie
Hlavní autoři:	Beer, N, Tribble, N, McCulloch, L, Roos, C, Johnson, P, Orho-Melander, M, Gloyn, A
Médium:	Journal article
Jazyk:	English
Vydáno:	Oxford University Press 2009

Podobné jednotky

Functional characterisation of the glucokinase regulatory protein gene variant P446L shows diminished regulation by fructose-6 phosphate resulting in increased glucokinase activity
Autor: Beer, N, a další
Vydáno: (2009)

Cellular characterisation of the GCKR P446L variant associated with type 2 diabetes risk
Autor: Rees, MG, a další
Vydáno: (2011)

Cellular characterisation of the GCKR P446L variant associated with type 2 diabetes risk.
Autor: Rees, MG, a další
Vydáno: (2012)

The GCKR-P446L gene variant predisposes to raised blood cholesterol and lower blood glucose in the P446L mouse-a model for GCKR rs1260326
Autor: Brian E. Ford, a další
Vydáno: (2023-06-01)

Inheritance of rare functional GCKR variants and their contribution to triglyceride levels in families.
Autor: Rees, MG, a další
Vydáno: (2014)

Evolution of hepatic glucose metabolism: liver-specific glucokinase deficiency explained by parallel loss of the gene for glucokinase regulatory protein (GCKR).
Autor: Zhao Yang Wang, a další
Vydáno: (2013-01-01)

Investigating novel mutational mechanisms for glucokinase mutations with near normal or paradoxical kinetics
Autor: Tribble, N, a další
Vydáno: (2009)

Naturally occurring glucokinase mutations are associated with defects in posttranslational S-nitrosylation.
Autor: Ding, S, a další
Vydáno: (2010)

Identification and functional characterisation of novel inactivating glucokinase mutations causing GCK-MODY in Slovakia
Autor: Valentinova, L, a další
Vydáno: (2011)

Prevalence of glucokinase (GCK) mutations in people with elevated fasting glucose levels: implications for clinical trials
Autor: Gloyn, A, a další
Vydáno: (2007)

Naturally occurring glucokinase mutations at the same amino acid residue cause opposite clinical phenotypes of hypo- and hyperglycaemia
Autor: Beer, N, a další
Vydáno: (2010)

Glucokinase (GCK) and other susceptibility genes for beta-cell dysfunction: the candidate approach.
Autor: Gloyn, A, a další
Vydáno: (2008)

The role of genetic variation in glucokinase and glucokinase regulatory protein in diabetes and related traits
Autor: Beer, N, a další
Vydáno: (2011)

Insights into glucokinase regulatory protein regulation from the cellular and kinetic characterisation of rare coding variants
Autor: Rees, MG, a další
Vydáno: (2010)

Functional analysis of GCKR mutations identified in subjects with hypertriglyceridaemia demonstrates the inherent challenges in clinical interpretation of rare variants
Autor: Raimondo, A, a další
Vydáno: (2012)

Additive genetic effect of GCKR, G6PC2, and SLC30A8 variants on fasting glucose levels and risk of type 2 diabetes.
Autor: Guanjie Chen, a další
Vydáno: (2022-01-01)

Additive genetic effect of GCKR, G6PC2, and SLC30A8 variants on fasting glucose levels and risk of type 2 diabetes
Autor: Guanjie Chen, a další
Vydáno: (2022-01-01)

Identification and functional characterisation of novel glucokinase mutations causing maturity-onset diabetes of the young in Slovakia.
Autor: Valentinova, L, a další
Vydáno: (2012)

TMG-123, a novel glucokinase activator, exerts durable effects on hyperglycemia without increasing triglyceride in diabetic animal models.
Autor: Yoshinori Tsumura, a další
Vydáno: (2017-01-01)

Effects of GCK, GCKR, G6PC2 and MTNR1B variants on glucose metabolism and insulin secretion.
Autor: Cheng Hu, a další
Vydáno: (2010-07-01)

Mutations in the third gene shown to alter fasting glucose levels in the population (G6PC2) are not a common cause of monogenic forms of pancreatic B-cell dysfunction.
Autor: Edghill, E, a další
Vydáno: (2009)

Permanent neonatal diabetes mellitus caused by a novel homozygous (T168A) glucokinase (GCK) mutation: initial response to oral sulphonylurea therapy.
Autor: Turkkahraman, D, a další
Vydáno: (2008)

A comprehensive map of human glucokinase variant activity
Autor: Sarah Gersing, a další
Vydáno: (2023-04-01)

Effects of genetic variants in ADCY5, GIPR, GCKR and VPS13C on early impairment of glucose and insulin metabolism in children.
Autor: Jan Windholz, a další
Vydáno: (2011-01-01)

Identification and functional characterisation of novel glucokinase mutations causing maturity-onset diabetes of the young in Slovakia.
Autor: Lucia Valentínová, a další
Vydáno: (2012-01-01)

Correlation of rare coding variants in the gene encoding human glucokinase regulatory protein with phenotypic, cellular, and kinetic outcomes.
Autor: Rees, MG, a další
Vydáno: (2012)

Large scale meta-analyses of fasting plasma glucose raising variants in GCK, GCKR, MTNR1B and G6PC2 and their impacts on type 2 diabetes mellitus risk.
Autor: Haoran Wang, a další
Vydáno: (2013-01-01)

A panel of diverse assays to interrogate the interaction between glucokinase and glucokinase regulatory protein, two vital proteins in human disease
Autor: Rees, MG, a další
Vydáno: (2014)

Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia.
Autor: Osbak, K, a další
Vydáno: (2009)

α-cell glucokinase suppresses glucose-regulated glucagon secretion
Autor: Basco, D, a další
Vydáno: (2018)

α-cell glucokinase suppresses glucose-regulated glucagon secretion
Autor: Davide Basco, a další
Vydáno: (2018-02-01)

Clinical investigation of glucokinase activators for the restoration of glucose homeostasis in diabetes
Autor: Ping Li, a další
Vydáno: (2024-05-01)

A panel of diverse assays to interrogate the interaction between glucokinase and glucokinase regulatory protein, two vital proteins in human disease.
Autor: Matthew G Rees, a další
Vydáno: (2014-01-01)

Small molecular glucokinase activators: has another new anti-diabetic therapeutic lost favour?
Autor: Rees, MG, a další
Vydáno: (2013)

Small molecular glucokinase activators: Has another new anti-diabetic therapeutic lost favour?
Autor: Rees, MG, a další
Vydáno: (2014)

Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.
Autor: Gloyn, A
Vydáno: (2003)

Activating glucokinase (GCK) mutations as a cause of medically responsive congenital hyperinsulinism: prevalence in children and characterisation of a novel GCK mutation.
Autor: Christesen, H, a další
Vydáno: (2008)

GCKR gene functional variants in type 2 diabetes and metabolic syndrome: do the rare variants associate with increased carotid intima-media thickness?
Autor: Hetyésy Katalin, a další
Vydáno: (2010-11-01)

A glucokinase-linked sensor in the taste system contributes to glucose appetite
Autor: Sandrine Chometton, a další
Vydáno: (2022-10-01)

Complete glucokinase deficiency is not a common cause of permanent neonatal diabetes.
Autor: Gloyn, A, a další
Vydáno: (2002)